Get the Stockscreener App
7.09
1.72%
+0.12
After Hours:
7.09
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) Forecast
The Titan Pharmaceuticals, Inc. (de) (TTNP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.8782, representing a -73.51% decrease from the current price of $7.09. The highest analyst price target is $2.2082, and the lowest is $1.5482.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TTNP Price Target
Average 1.1894
(-83.22% Downside)
Is Titan Pharmaceuticals, Inc. (de) (TTNP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.77 | Neutral |
| STOCH(9,6) | 16.19 | Buy |
| STOCHRSI(14) | 40.16 | Neutral |
| MACD(12,26) | -0.00706 | Sell |
| ADX(14) | 26.69 | Buy |
| William %R | -85.34 | Buy |
| CCI(14) | 46.94 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.1277
Sell
|
7.0941
Sell
|
| MA20 |
7.121
Sell
|
7.1235
Sell
|
| MA50 |
7.2763
Sell
|
6.7094
Buy
|
| MA100 |
4.954
Buy
|
5.4203
Buy
|
| MA200 |
2.7213
Buy
|
3.8018
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, TTNP could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 6 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on TTNP, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 49.77 indicates that TTNP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 16.19 indicates that TTNP is oversold. This indicates that TTNP price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.16 indicates that TTNP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.69 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 46.94 indicates that TTNP is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TTNP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Titan Pharmaceuticals, Inc. (de) financial reports and earnings history, Titan Pharmaceuticals, Inc. (de) (TTNP) stock could reach $2.2365 by 2030, $1.0492 by 2040 and $1.3905 by 2050. See the projected annual prices until 2050 of the Titan Pharmaceuticals, Inc. (de) stock below:
- Titan Pharmaceuticals, Inc. (de) (TTNP) is expected to reach an average price of $0.4832 in 2035, with a high prediction of $0.6326 and a low estimate of $0.3753. This indicates an $-93.19% rise from the last recorded price of $7.09.
- Titan Pharmaceuticals, Inc. (de) (TTNP) stock is projected to chart a bullish course in 2040, with an average price target of $0.8393, representing an $-88.16% surge from its current level. The forecast ranges from a conservative $0.8127 to a sky-high $1.0492.
- Our analysts predict Titan Pharmaceuticals, Inc. (de) (TTNP) to jump -79.66% by 2045, soaring from $1.3218 to an average price of $1.442, potentially reaching $1.7119. While $1.3218 is the low estimate, the potential upside is significant.
- Titan Pharmaceuticals, Inc. (de) (TTNP) stock is expected to climb by 2050, reaching an average of $1.3605, a $-80.81% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.3905 and $1.0004, respectively, highlighting the market's uncertainty.
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) Year by Year Forecast
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) Price Forecast for 2024
Our forecast for TTNP stock price in 2024 now indicates an average price target of $1.3309 with a high forecast of $2.4781 and a low forecast of $0.1836. The average prediction reflects an decrease of -81.23% from the last recorded price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $1.7083 | $1.5482 | $2.2082 | -75.91% |
| June, 2024 | $1.1782 | $1.1183 | $1.7983 | -83.38% |
| July, 2024 | $1.2785 | $1.1283 | $1.9883 | -81.97% |
| August, 2024 | $1.1484 | $1.1384 | $1.4184 | -83.80% |
| September, 2024 | $0.4465 | $0.4285 | $1.1684 | -93.70% |
| October, 2024 | $0.3221 | $0.3115 | $0.5685 | -95.46% |
| November, 2024 | $0.2039 | $0.1907 | $0.6173 | -97.12% |
| December, 2024 | $0.1902 | $0.1836 | $0.2476 | -97.32% |
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) Price Forecast for 2025
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) is expected to reach an average price of $0.3722 in 2025, with a high prediction of $0.5737 and a low estimate of $0.1706. This indicates an -94.75% fall from the last recorded price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.1952 | $0.1706 | $0.2437 | -97.25% |
| February, 2025 | $0.2837 | $0.1837 | $0.3287 | -96.00% |
| March, 2025 | $0.2826 | $0.2307 | $0.4587 | -96.01% |
| April, 2025 | $0.3311 | $0.2141 | $0.5737 | -95.33% |
| May, 2025 | $0.2638 | $0.2188 | $0.3288 | -96.28% |
| June, 2025 | $0.2874 | $0.2379 | $0.2994 | -95.95% |
| July, 2025 | $0.3047 | $0.2675 | $0.4469 | -95.70% |
| August, 2025 | $0.3428 | $0.2887 | $0.4978 | -95.16% |
| September, 2025 | $0.3209 | $0.2991 | $0.474 | -95.47% |
| October, 2025 | $0.309 | $0.3041 | $0.3891 | -95.64% |
| November, 2025 | $0.2186 | $0.1995 | $0.3251 | -96.92% |
| December, 2025 | $0.1886 | $0.1815 | $0.2636 | -97.34% |
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) Price Forecast for 2026
The predicted value for Titan Pharmaceuticals, Inc. (de) (TTNP) in 2026 is set at an average of $2.3814. Estimates vary from a peak of $4.6395 to a trough of $0.1233, indicating an -66.41% surge from the present price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.1696 | $0.142 | $0.28 | -97.61% |
| February, 2026 | $0.2064 | $0.1233 | $0.3243 | -97.09% |
| March, 2026 | $3.2894 | $0.1793 | $4.3293 | -53.61% |
| April, 2026 | $3.2194 | $3.0394 | $3.7094 | -54.59% |
| May, 2026 | $3.9595 | $3.1694 | $4.6395 | -44.15% |
| June, 2026 | $2.8295 | $2.5895 | $4.0395 | -60.09% |
| July, 2026 | $2.3196 | $2.1796 | $3.0395 | -67.28% |
| August, 2026 | $2.4596 | $2.2096 | $2.6496 | -65.31% |
| September, 2026 | $2.5297 | $2.3196 | $2.7297 | -64.32% |
| October, 2026 | $2.4847 | $2.3697 | $3.1297 | -64.95% |
| November, 2026 | $2.2098 | $2.1798 | $2.5178 | -68.83% |
| December, 2026 | $2.1598 | $2.0998 | $2.4098 | -69.54% |
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Titan Pharmaceuticals, Inc. (de) (TTNP) is $1.2949, with a high forecast of $2.2098 and a low forecast of $0.3799. This indicates an -81.74% decrease from the last price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.8899 | $1.8599 | $2.2098 | -73.34% |
| February, 2027 | $1.7805 | $1.5999 | $2.0599 | -74.89% |
| March, 2027 | $1.51 | $1.37 | $1.9894 | -78.70% |
| April, 2027 | $1.16 | $1.13 | $1.53 | -83.64% |
| May, 2027 | $0.9597 | $0.9435 | $1.49 | -86.46% |
| June, 2027 | $1.2001 | $0.8801 | $1.3201 | -83.07% |
| July, 2027 | $0.9662 | $0.9502 | $1.2501 | -86.37% |
| August, 2027 | $0.9702 | $0.8928 | $1.1402 | -86.32% |
| September, 2027 | $0.7273 | $0.6913 | $1.0102 | -89.74% |
| October, 2027 | $0.4483 | $0.3799 | $0.7703 | -93.68% |
| November, 2027 | $0.6155 | $0.3913 | $0.7103 | -91.32% |
| December, 2027 | $1.2504 | $0.5419 | $1.4704 | -82.36% |
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) Price Forecast for 2028
In 2028, Titan Pharmaceuticals, Inc. (de) (TTNP) is projected to reach an average price of $1.1807, with a high projection of $1.6205 and a low estimate of $0.7409. This indicates an -83.35% fall from the last price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.5105 | $1.2104 | $1.6205 | -78.70% |
| February, 2028 | $1.4705 | $1.2805 | $1.6005 | -79.26% |
| March, 2028 | $1.0806 | $1.0405 | $1.5305 | -84.76% |
| April, 2028 | $1.0306 | $0.9806 | $1.1706 | -85.46% |
| May, 2028 | $0.8427 | $0.8407 | $1.0706 | -88.11% |
| June, 2028 | $0.8207 | $0.7557 | $1.1247 | -88.42% |
| July, 2028 | $1.0808 | $0.7508 | $1.1108 | -84.76% |
| August, 2028 | $0.981 | $0.9508 | $1.1208 | -86.16% |
| September, 2028 | $0.8909 | $0.8531 | $1.0308 | -87.43% |
| October, 2028 | $0.8209 | $0.7409 | $0.8909 | -88.42% |
| November, 2028 | $0.8187 | $0.762 | $0.8409 | -88.45% |
| December, 2028 | $0.803 | $0.751 | $0.861 | -88.67% |
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) Price Forecast for 2029
The 2029 price forecast for Titan Pharmaceuticals, Inc. (de) Stock (TTNP) is $1.3811 on average, with a high prediction of $2.5063 and a low estimate of $0.256. This represents an -80.52% decrease from the previous price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6461 | $0.6211 | $0.8606 | -90.89% |
| February, 2029 | $0.6441 | $0.5361 | $0.7295 | -90.92% |
| March, 2029 | $0.5812 | $0.4592 | $0.6747 | -91.80% |
| April, 2029 | $0.5143 | $0.4812 | $0.586 | -92.75% |
| May, 2029 | $0.4121 | $0.3914 | $0.5413 | -94.19% |
| June, 2029 | $0.451 | $0.344 | $0.6013 | -93.64% |
| July, 2029 | $0.3068 | $0.2991 | $0.4482 | -95.67% |
| August, 2029 | $0.279 | $0.256 | $0.3314 | -96.06% |
| September, 2029 | $1.5061 | $0.2661 | $1.5261 | -78.76% |
| October, 2029 | $1.4962 | $1.2361 | $2.2262 | -78.90% |
| November, 2029 | $1.8163 | $1.6863 | $2.5063 | -74.38% |
| December, 2029 | $1.7264 | $1.5064 | $2.0764 | -75.65% |
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) Price Forecast for 2030
Titan Pharmaceuticals, Inc. (de) Stock (TTNP) is expected to reach an average price of $1.2179 in 2030, with a high forecast of $2.2365 and a low forecast of $0.1992. This signifies an -82.82% decrease from the last price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.7565 | $1.6665 | $2.2365 | -75.23% |
| February, 2030 | $1.3966 | $1.1466 | $1.8266 | -80.30% |
| March, 2030 | $1.3068 | $1.2317 | $2.0167 | -81.57% |
| April, 2030 | $1.1668 | $1.1268 | $1.4467 | -83.54% |
| May, 2030 | $0.4749 | $0.4569 | $1.1769 | -93.30% |
| June, 2030 | $0.3506 | $0.34 | $0.5969 | -95.05% |
| July, 2030 | $0.2405 | $0.2192 | $0.6459 | -96.61% |
| August, 2030 | $0.2188 | $0.2122 | $0.2471 | -96.91% |
| September, 2030 | $0.2146 | $0.1992 | $0.2723 | -96.97% |
| October, 2030 | $0.3271 | $0.2124 | $0.4014 | -95.39% |
| November, 2030 | $0.3113 | $0.2795 | $0.4875 | -95.61% |
| December, 2030 | $0.2746 | $0.2429 | $0.6025 | -96.13% |
1.53%
3.38%
Cap:
|
Volume (24h):